Sartorius AG

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

D6705R119
SEDOL

5843329
CIK

N/A

sartorius.com
LEI: 529900EQV2DY4FOAMU38
FIGI: BBG000BGC542
SRT3

Sartorius AG
GICS: 35203010 · Sector: Laboratory equipment · Sub-Sector: -
AI
PROFILER
NAME
Sartorius AG
ISIN
DE0007165631
TICKER
SRT3
MIC
XETR
REUTERS
SATG_p.DE
BLOOMBERG
SRT3 GR
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Tue, 28.01.2025

Göttingen, Germany | January 28, 2025 Sartorius closes fiscal 2024 with very good fourth quarter and positive trend; full-year guidance achieved   Preliminary business results for 2024: sales revenue at 3,381 million euros (+ 0.1 percent in constant currencies), underlying profit margin reaches 28.0 percent Order intake + 10.8 percent, demand i...
Fri, 06.12.2024

Göttingen, December 6, 2024 Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG   Grosse to take over as Group CEO on July 1, 2025 At its meeting today, the Supervisory Board of Sartorius AG appointed Dr. Michael Grosse Chief Executive Officer of Sartorius. He will take over this position on July 1, 2025, from D...
Fri, 06.12.2024

Disclosure of inside information according to Article 17 MAR Michael Grosse to become Chief Executive Officer of Sartorius AG At its meeting today, the Supervisory Board of Sartorius AG resolved to appoint Dr. Michael Grosse as member of the Executive Board and Chief Executive Officer of the company with effect from July 1, 2025, for a term of th...
Thu, 17.10.2024

Göttingen, Germany | October 17, 2024 Nine-month results in line with expectations: sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash flow   Group sales revenue down only slightly by - 2.0 percent after nine months; order intake up 6.6 percent Underlying EBITDA margin reaches 27.7 percent; further i...
Thu, 18.07.2024

Göttingen, July 18, 2024 Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive   Sales revenue slightly down 2.2 percent after six months; growth of 3.6 percent in second quarter Underlying EBITDA margin at a ...
Thu, 18.07.2024

Disclosure of inside information according to Article 17 MAR Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024 In a continuously very challenging and volatile market environment, the life science group Sartorius closed the first half of the year with a positive trend in sales revenue development. In view of t...
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S